A small-molecule inhibitor of the ribonucleolytic activity of human angiogenin that possesses antitumor activity

The results of previous preclinical and clinical studies have identified angiogenin (ANG) as a potentially important target for anticancer therapy. Here we report the design and implementation of a high-throughput screening assay to identify small molecules that bind to the ribonucleolytic active si...

Popoln opis

Bibliografske podrobnosti

izdano v:	Proc Natl Acad Sci U S A
Principais autores:	Kao, Richard Y. T., Jenkins, Jeremy L., Olson, Karen A., Key, Marc E., Fett, James W., Shapiro, Robert
Format:	Artigo
Jezik:	Inglês
Izdano:	National Academy of Sciences 2002
Teme:	Biological Sciences
Online dostop:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC126625/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12118120/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.152342999
Oznake:	Označite Brez oznak, prvi označite!